# OnCo record tracon (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/tracon/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "tracon" ;
  schema:name "Tracon Pharmaceuticals"@en ;
  schema:alternateName "Tracon Pharmaceuticals Inc."@en, "TRACON"@en ;
  schema:description "Tracon was a San Diego biotech whose endoglin antibody carotuximab failed a phase 3 trial in angiosarcoma and whose subcutaneous PD-L1 antibody envafolimab missed in sarcoma; it wound down in 2024."@en ;
  schema:url <https://onco.cc/companies/tracon/>, <http://www.traconpharma.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <http://www.traconpharma.com>, <https://clinicaltrials.gov/search?lead=Tracon%20Pharmaceuticals%20Inc.>, <https://www.wikidata.org/wiki/Q30289078> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/sarcoma/> ;
  onco:drugs <https://onco.cc/drugs/envafolimab/> ;
  onco:terms <https://onco.cc/terms/pivotal-trial/>, <https://onco.cc/terms/clinical-trial/> .